Latest Information

Publications

• Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights
• Synacthen (tetracosactide) Important Safety Information from SOBI AB as approved by the Irish Medicines Board
• Avastin (bevacizumab) Important Safety Information from Roche as approved by the Irish Medicines Board
• Protelos (strontium ranelate) Important Safety Information from Servier as approved by the Irish Medicines Board
• Increlex (mecasermin) Important Safety Information from Ipsen as approved by the Irish Medicines Board

Links

• Department of Agriculture, Food and the Marine
• Department of Health
• Rare Disease Day - 28 February 2010
• The Health Protection Surveillance Centre (HPSC)
• European Medicines Agency

News

• Irish Medicines Board’s Drug Safety Newsletter celebrates 50th edition
• Irish Medicines Board, Customs and Gardai in global INTERPOL operation targeting counterfeit and illegal medicines
• Chelford childrens ‘5 Face Paint’ set – Safety information for consumers
• IMB gives new advice for use of cough and cold medicines in children
• European Medicines Agency publishes update on pioglitazone-containing medicines review

Events

• IMB Pharmacovigilance/Safety-based conference